London, 21 August 2014: TechNavio, the independent tech-focused global research firm, has published a report on the Global Biotechnology Reagent market 2014-2018, which is expected to post a CAGR of 9.79 percent during 2013-2018.
Biotechnology reagents are chemical compounds or substances added to the system to detect and examine another substance and provide latest reading. These reagents are used in the research fields of molecular biotechnology, human immunology, genetics, diagnosis, biosciences, and in education.
“Increased use of biotechnology reagents in various disciplines will drive the growth of the Global Biotechnology Reagents market during the forecast period,” says Faisal Ghaus, Vice President of TechNavio.
“Research in emerging fields such as DNA chips, metabolomics, combinational chemistry, and high-throughput screening has increased the use of biomedical research reagents and kits.”
Key Market Drivers
- High Investment in R&D Activities by Biotechnology Companies
- Rise in Demand for Biotechnology Reagents
- Advances in Biotechnology Instrumentation Market
Key Market Trends
- Increase in Biomedical Research Activities
- Increase in Use of Therapeutic Reagents
- Advances in Stem Cell Research
Key Market Vendors
- Agilent Technologies Inc.
- BD
- Bio-Rad Laboratories
- F. Hoffmann-La Roche
- Sigma-Aldrich
- Thermo Fisher Scientific Inc.
To define the market circumstances in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
